|
|
|
|
|
Session 50
Poster Presentations Neutralizing Antibodies Session Day and Time: Wednesday 1:30 - 3:30 pm Room: Hall D |
Background: The identification
of reliable immune correlates of AIDS vaccine protection in the SIV/monkey
vaccine model has proven elusive. Using qualitative assays of antibody
conformational dependence and avidity, we have previously described a complex evolution
of envelope-specific antibody responses associated with the development of
protective immunity in monkeys inoculated with attenuated strains of SIV. The
current studies were designed to examine the nature of the antibody maturation
to attenuated SIV/17E and evaluate potential immune correlates of vaccine
protection based on the analysis of antibody responses to specific envelope
domains, designated “domain-specific” serology.
Methods: To achieve the
analyses of predominantly conformationally-dependent antibody responses, we
have produced a novel panel of HIV/SIV chimeric envelope antigens in which
specific domains of the SIV envelope have been substituted into the HIV-1
envelope background and expressed in the vaccinia system. These chimeric envelope
antigens have been used in serological assays to monitor the quantitative and
qualitative progression of antibody responses associated with the immune
maturation in monkeys inoculated with an attenuated SIV vaccine.
Results: The results of
these serological assays show different levels of antibody responses to
individual domains of the SIV envelope during immune maturation. Qualitative
antibody to these individual envelope domains also varies. These results show
that there is a distinct maturation of antibody responses to individual,
conformational domains of the SIV envelope glycoprotein that can be predictive
of immune maturation protection in these monkeys.
Conclusions: The results of
these domain-specific serological assays reveal new aspects of the antibody
maturation to attenuated SIV vaccines that better characterize the nature of
antibody responses associated with mature, protective immunity and that provide
novel parameters that can be evaluated further as potential immune correlates
of vaccine protection.